PEDIATRICS Vol. 69 No. 3 March 1982, pp. 386-387
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaw, E. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaw, E. B.

Pertussis Vaccine: Still an Open Question?

Edward B. Shaw MD1

1 University of California Medical Center, San Francisco, CA 94143

The Public Health authorities in Britain have decided that pertussis vaccine is less risky at early ages than the whooping cough infection. This vaccine is usually given together with diphtheria, tetanus, and poliomyelitis vaccine. Only the pertussis component involves a significant risk of reaction; however, its use at an early age is believed to protect against the greater severity of the disease in infancy.

Because of the severity of the adverse reactions, this vaccine is not recommended for routine use past ages 5 to 7 years.